TABLE 2.
Covariatesb | Hazard Ratio | 95% Confidence Interval | P |
---|---|---|---|
Adult-onset IBD c | 0.580 | 0.386–0.871 | <0.01 |
Prior GI Surgery | 1.440 | 0.913–2.270 | 0.12 |
Prior Hospitalization | 1.455 | 0.881–2.402 | 0.14 |
Medication at Cohort Entryd | 1.352 | 0.895–2.042 | 0.15 |
Corticosteroids at Cohort Entry | 1.359 | 0.889–2.079 | 0.16 |
Type of IBDe | 1.294 | 0.876–1.911 | 0.20 |
aComposite safety defined as the first occurrence of infection, malignancy, or death following cohort entry.
bCovariates were selected via backward regression with P cutoff of 0.2.
cAdult-onset IBD defined as age of IBD diagnosis younger than 60 years, compared with elderly-onset IBD (60 years and older at diagnosis) as baseline.
dMedication at cohort entry defined as a binary categorical variable: either taking no medications/5-aminosalicylates at entry (baseline) or taking immunomodulators/biologics at entry.
eType of IBD defined as a binary categorical variable: either ulcerative colitis or Crohn’s disease, with Crohn’s disease as baseline
Abbreviations: IBD, inflammatory bowel diseases; GI, gastrointestinal